Position in HAE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,028,331
-$1,700,390 QoQ
Shares Held
71,475
0.0% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HAE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $183,504,116 across 22 Medical Devices names. HAE ranks #15 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMDX |
TransMedics Group, Inc.
|
244,382 | $24,294,014 | |
| 2 | ESTA |
Establishment Labs Holdings Inc.
|
427,472 | $24,271,860 | |
| 3 | AORT |
Artivion, Inc.
|
425,282 | $15,573,826 | |
| 4 | BVS |
Bioventus Inc.
|
1,541,282 | $14,071,904 | |
| 5 | ENOV |
Enovis CORP
|
611,090 | $13,902,297 | |
| 6 | TNDM |
Tandem Diabetes Care Inc
|
696,590 | $13,353,630 | |
| 7 | APYX |
Apyx Medical Corp
|
2,611,224 | $9,635,416 | |
| 8 | CBLL |
Ceribell, Inc.
|
515,720 | $9,453,147 |
All Filings in HAE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,028,331 | 71,475 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,728,721 | 71,475 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $34,178,535 | 701,242 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $94,833,562 | 1,271,057 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $73,800,360 | 1,161,296 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $90,047,165 | 1,153,268 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $97,303,687 | 1,210,546 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $97,594,760 | 1,179,678 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $108,105,504 | 1,266,614 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $82,633,016 | 966,355 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $84,881,529 | 947,550 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $77,161,700 | 906,292 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $69,820,643 | 843,754 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $64,922,586 | 825,462 | Shares | Sole | 2023-05-23 | |
| 2022-09-30 | $64,762,036 | 874,808 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $54,854,510 | 841,585 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $47,872,965 | 757,244 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $37,558,048 | 708,108 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $69,485,831 | 984,358 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $40,087,025 | 601,546 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $52,017,620 | 468,585 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $71,102,275 | 598,756 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $50,919,798 | 583,608 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $44,170,365 | 493,193 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $37,532,454 | 376,605 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||